For a long time, the likelihood of surviving pancreatic cancer has been extremely low.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045
FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival
minute read
by The Conversation | August 26, 2026
